Jasper Therapeutics Appoints Herb Cross As Chief Financial
09/25/23, 12:49 PM
Location
redwood cityIndustry
therapeutics
biotechnology
health care
Position
chief financial officer
REDWOOD CITY, Calif., Sept. 25, 2023 -- Jasper Therapeutics, Inc. , a biotechnology company focused on the development of briquilimab, a novel antibody therapy targeting c-Kit to address diseases such as chronic spontaneous urticaria , lower to intermediate risk myelodysplastic syndromes as well as novel stem cell transplant conditioning regimens, today announced the appointment of Herb Cross, an experienced senior financial executive, as the company’s Chief Financial Officer
Company Info
Location
redwood city, california, united states
Additional Info
Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies.
Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.
Related People
Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Hh
Hh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more